{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:56:16Z","timestamp":1790592976036,"version":"4.1.0"},"reference-count":72,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Pain is one of the most frequent and burdensome symptoms of pancreatic cancer and may substantially impair quality of life throughout the disease trajectory. Its complex and evolving etiology, involving visceral, neuropathic, somatic, and treatment-related mechanisms, frequently makes adequate pain control challenging. This critical narrative review provides a multidisciplinary overview of pancreatic cancer-associated pain management, integrating oncological treatment, palliative and pharmacological care, and interventional pain management into a practical clinical framework. Anticancer therapies, including chemotherapy and radiotherapy, may provide clinically meaningful analgesia in addition to their disease-controlling effect. Early integration of palliative care enables repeated symptom assessment, individualized pharmacological treatment, and management of the psychological, social, and spiritual dimensions of total pain. When conventional analgesic strategies provide insufficient relief or cause intolerable adverse effects, interventional techniques such as coeliac plexus neurolysis, splanchnic neurolysis, or intrathecal drug delivery can complement ongoing oncological and palliative treatment. Rather than following a rigid stepwise analgesic approach, pancreatic cancer-associated pain management should be individualized according to pain mechanism, disease stage and anatomy, previous treatments, functional status, expected survival, and patient preferences. Based on the available evidence and multidisciplinary clinical considerations, we propose a practical patient-centered pathway that dynamically integrates disease-directed, pharmacological, supportive, and interventional strategies throughout the disease course. Early multidisciplinary collaboration and continuous reassessment may facilitate timely treatment escalation and improve pain control while minimizing treatment burden.<\/jats:p>","DOI":"10.3390\/cancers18193127","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:00:34Z","timestamp":1790589634000},"page":"3127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pancreatic Cancer-Associated Pain Management Beyond Opioids: Integrating Oncological Treatment, Palliative Care, and Interventional Pain Medicine"],"prefix":"10.3390","volume":"18","author":[{"given":"Ferenc","family":"Zelenai","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Pain Unit, National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Bakos","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Pain Unit, National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vill\u0151","family":"S\u00fcller-Torma","sequence":"additional","affiliation":[{"name":"Palliative Care Unit, National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdolna","family":"Dank","sequence":"additional","affiliation":[{"name":"National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-0638","authenticated-orcid":false,"given":"Ildik\u00f3","family":"Madurka","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Pain Unit, National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Palliative Care Unit, National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"ECIS (2026, July 19). European Cancer Information System. Available online: https:\/\/ecis.jrc.ec.europa.eu\/."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Faghih, M., Damm, M., Gutzler, C., Hirth, M., Kassik, M.-T., Kuhlmann, L., Michl, P., Olesen, S.S., Phillips, A.E., and Singh, V.K. (2026). Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma. J. Gastroenterol., 1\u201312.","DOI":"10.1007\/s00535-026-02423-3"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/CCO.0000000000001251","article-title":"Pain management in pancreatic cancer: Time to change our strategy!","volume":"38","author":"Blero","year":"2026","journal-title":"Curr. Opin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.1002\/onco.13796","article-title":"Pancreas Cancer-Associated Pain Management","volume":"26","author":"Coveler","year":"2021","journal-title":"Oncologist"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wang, J., Chen, Y., Li, X., and Zou, X. (2021). Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13184594"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/MPA.0000000000001094","article-title":"Association Between Opioid Use and Survival Time in Patients with Unresectable Pancreatic Cancer","volume":"47","author":"Oh","year":"2018","journal-title":"Pancreas"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of Palliative Care into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.11578","article-title":"Measuring the side effects of taxane therapy in oncology","volume":"98","author":"Cella","year":"2003","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/COC.0000000000000385","article-title":"Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta","volume":"41","author":"Kim","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2147\/DDDT.S165851","article-title":"Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer","volume":"12","author":"Blasi","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00423-026-04121-3","article-title":"Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic cancer undergoing neoadjuvant FOLFIRINOX chemotherapy: Results from a prospective multicenter trial","volume":"411","author":"Ceelen","year":"2026","journal-title":"Langenbeck\u2019s Arch. Surg."},{"key":"ref_14","first-page":"2407","article-title":"Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment","volume":"30","author":"Schafthuizen","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial","volume":"387","author":"Li","year":"2016","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2018.09.029","article-title":"Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin","volume":"106","author":"Hubner","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2605555","article-title":"Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer","volume":"395","author":"Wainberg","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13014-025-02776-8","article-title":"Magnetic resonance-guided online adaptive stereotactic body radiotherapy for advanced inoperable pancreatic cancer: A prospective study","volume":"21","author":"Wang","year":"2025","journal-title":"Radiat. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2021.07.009","article-title":"Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial","volume":"162","author":"Zhu","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eclinm.2026.103968","article-title":"Celiac plexus radiosurgery for retroperitoneal pain in advanced cancer: A pre-specified secondary analysis of health-related quality of life in a phase II single-arm trial","volume":"95","author":"Barry","year":"2026","journal-title":"eClinicalMedicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1470-2045(24)00223-7","article-title":"Celiac plexus radiosurgery for pain management in advanced cancer: A multicentre, single-arm, phase 2 trial","volume":"25","author":"Lawrence","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijrobp.2023.08.055","article-title":"Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial","volume":"118","author":"Valverde","year":"2023","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ji, X., Zhou, B., Ding, W., Wang, J., Jiang, W., Li, Y., Hu, J., and Sun, X. (2022). Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.925043"},{"key":"ref_25","first-page":"5547","article-title":"Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: Data from a multicenter cohort study","volume":"28","author":"Siemens","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jpainsymman.2026.02.004","article-title":"Early Supportive Versus Standard Care in Phase I Cancer Trials: A Randomized Controlled Trial","volume":"71","author":"Salazar","year":"2026","journal-title":"J. Pain Symptom Manag."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2314660","DOI":"10.1001\/jamanetworkopen.2023.14660","article-title":"Effect of Perioperative Palliative Care on Health-Related Quality of Life Among Patients Undergoing Surgery for Cancer","volume":"6","author":"Aslakson","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_28","first-page":"116","article-title":"Pain at the end of life in patients with cancer: A population-based study on prevalence, relief, and the role of pain assessment","volume":"34","author":"Slotman","year":"2026","journal-title":"Support. Care Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Czerw, A., Religioni, U., and Bana\u015b, T. (2020). Perception of cancer in patients diagnosed with the most common gastrointestinal cancers. BMC Palliat. Care, 19.","DOI":"10.1186\/s12904-020-00650-w"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"DeSomma, A., Maletz, S., Basinski, T.L., Morales, R., de Castria, T.B., Bloomston, M., Chen, D.-T., Douglas, W.G., Huguet, K.L., and Jeong, D. (2025). Lifetime stressor exposure and depression among patients with pancreatic cancer: Insights from the Florida Pancreas Collaborative. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-15007-w"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Froicu, E.-M., Onicescu, O.-M., Creang\u0103-Murariu, I., Dasc\u0103lu, C., Gafton, B., Afr\u0103s\u00e2nie, V.-A., Alexa-Stratulat, T., Marinca, M.-V., Pu\u0219ca\u0219u, D.-M., and Miron, L. (2025). Modeling Pain Dynamics and Opioid Response in Oncology Inpatients: A Retrospective Study with Application to AI-Guided Analgesic Strategies in Colorectal Cancer. Medicina, 61.","DOI":"10.3390\/medicina61101741"},{"key":"ref_32","first-page":"163","article-title":"Implementation of pharmaceutical strategies using the PDCA cycle for standardized management of cancer pain medications","volume":"33","author":"Luo","year":"2025","journal-title":"Support. Care Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/cam4.4610","article-title":"Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015","volume":"11","author":"Lu","year":"2022","journal-title":"Cancer Med."},{"key":"ref_34","first-page":"e250032","article-title":"Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Swarm","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"oyaf215","DOI":"10.1093\/oncolo\/oyaf215","article-title":"Efficacy and safety of combining low-dose methadone with ongoing opioid treatment for uncontrolled cancer pain: An open-label single-arm study","volume":"30","author":"Hasegawa","year":"2025","journal-title":"Oncologist"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"F\u00fcrst, P., Lundstr\u00f6m, S., and Strang, P. (2020). Methadone in Swedish specialized palliative care\u2014Is it the magic bullet in complex cancer-related pain?. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230845"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e050182","DOI":"10.1136\/bmjopen-2021-050182","article-title":"Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: A JORTC-PAL16 trial protocol","volume":"12","author":"Matsuoka","year":"2022","journal-title":"BMJ Open"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.14309\/ctg.0000000000000760","article-title":"Intravenous Lidocaine for Refractory Pain in Patients with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Multicenter Prospective Nonrandomized Pilot Study","volume":"15","author":"Augustinus","year":"2024","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pezzilli, R., Caccialanza, R., Capurso, G., Brunetti, O., Milella, M., and Falconi, M. (2020). Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer. Cancers, 12.","DOI":"10.3390\/cancers12020275"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e259057","DOI":"10.1136\/bcr-2023-259057","article-title":"Immune checkpoint inhibitor associated diarrhoea","volume":"17","author":"Adams","year":"2024","journal-title":"BMJ Case Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2169\/internalmedicine.8611-21","article-title":"A Case Report of Pancreatic Exocrine Insufficiency in Intraductal Papillary Mucinous Carcinoma Presenting with Leg Edema Treated with Pancreatic Exocrine Replacement Therapy","volume":"61","author":"Tanaka","year":"2022","journal-title":"Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamasurg.2023.7872","article-title":"Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands","volume":"159","author":"Mackay","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e70260","DOI":"10.1002\/pon.70260","article-title":"Living with Advanced Pancreatic Cancer: Patients\u2019 Experiences of Daily Life","volume":"34","author":"Bergqvist","year":"2025","journal-title":"Psycho-Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/curroncol31050194","article-title":"Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study","volume":"31","author":"Moffat","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e70135","DOI":"10.1002\/pon.70135","article-title":"Pancreatic Cancer Patients Supportive Care Needs: A Qualitative Analysis","volume":"34","author":"Benzo","year":"2025","journal-title":"Psycho-Oncology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1097\/SLA.0000000000004897","article-title":"Psychosocial Stress Before Major Oncologic Operations","volume":"274","author":"Shinall","year":"2021","journal-title":"Ann. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/pon.6151","article-title":"Meaning-centered pain coping skills training for patients with metastatic cancer: Results of a randomized controlled pilot trial","volume":"32","author":"Winger","year":"2023","journal-title":"Psycho-Oncol."},{"key":"ref_48","first-page":"CD007568","article-title":"Telephone interventions for symptom management in adults with cancer","volume":"2020","author":"Ream","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Hillen, B., Oestreicher, G., Schwab, L., Enders, K., Simon, P., Elme, A., Ben-Aharon, I., Goshenlago, T., Neuzillet, C., and Sclafani, F. (2025). Digital and AI-Assisted Multimodal Supportive Care, Combining Physical Activity, Nutrition, and Pain Management During Chemotherapy for Advanced Pancreatic Cancer Patients: Study Protocol of the European Multicenter Randomized Controlled Trial of the RELEVIUM Project. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14867-6"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e64983","DOI":"10.2196\/64983","article-title":"Exploring Barriers and Facilitators to Engagement of an Online Acceptance and Commitment Therapy Intervention for Cancer Survivors with Chronic Painful Chemotherapy-Induced Peripheral Neuropathy: Qualitative Interview Study","volume":"11","author":"Smeets","year":"2025","journal-title":"JMIR Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"103175","DOI":"10.1016\/j.ejon.2026.103175","article-title":"Exploring supportive care needs and future research directions in pancreatic cancer: A focus group study with patients, caregivers and health care professionals","volume":"82","author":"Mikkelsen","year":"2026","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/pon.6020","article-title":"Increased pain catastrophizing longitudinally predicts worsened pain severity and interference in patients with chronic pain and cancer: A collaborative health outcomes information registry study (CHOIR)","volume":"31","author":"Wilson","year":"2022","journal-title":"Psycho-Oncology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/pon.5975","article-title":"Psychosocial characteristics of chronic pain in cancer survivors referred to an Australian multidisciplinary pain clinic","volume":"31","author":"Glare","year":"2022","journal-title":"Psycho-Oncology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e70005","DOI":"10.1002\/pon.70005","article-title":"Music Therapy for Pain Management for People with Advanced Cancer: A Randomized Controlled Trial","volume":"33","author":"Bradt","year":"2024","journal-title":"Psycho-Oncology"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"F\u00fcrst, P., Lundstr\u00f6m, S., Klepstad, P., and Strang, P. (2020). Continuous subcutaneous infusion for pain control in dying patients: Experiences from a tertiary palliative care center. BMC Palliat. Care, 19.","DOI":"10.1186\/s12904-020-00681-3"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/02692163231220225","article-title":"Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation: An international Delphi study","volume":"38","author":"Surges","year":"2024","journal-title":"Palliat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Rijpstra, M., Vissers, K., Belar, A., Van der Elst, M., Surges, S.M., Adile, C., Roj\u00ed, R., Grassi, Y., Bronkhorst, E., and Mercadante, S. (2024). Assessment of the efficacy of palliative sedation in advanced cancer patients by evaluating discomfort levels: A prospective, international, multicenter observational study. BMC Med., 22.","DOI":"10.1186\/s12916-024-03829-7"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpainsymman.2025.12.021","article-title":"Relatives and Healthcare Providers\u2019 Psychological Adjustment at Continuous Deep Sedation Initiation","volume":"71","author":"Locatelli","year":"2025","journal-title":"J. Pain Symptom Manag."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Yoon, W.J., Oh, Y., Yoo, C., Jang, S., Cho, S.-S., Suh, J.-H., Choi, S.-S., and Park, D.H. (2020). EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061666"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.291.9.1092","article-title":"Effect of Neurolytic Celiac Plexus Block on Pain Relief, Quality of Life, and Survival in Patients with Unresectable Pancreatic Cancer","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/papr.13143","article-title":"Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer","volume":"22","author":"Okita","year":"2022","journal-title":"Pain Pr."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Grigoriadis, S., Tsitskari, M., Ioannidi, M., Zavridis, P., Kotsantis, I., Kelekis, A., and Filippiadis, D. (2021). Computed Tomography-Guided Percutaneous Radiofrequency Ablation of the Splanchnic Nerves as a Single Treatment for Pain Reduction in Patients with Pancreatic Cancer. Diagnostics, 11.","DOI":"10.3390\/diagnostics11020303"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/ejp.1274","article-title":"Comparison between radiofrequency ablation and chemical neurolysis of thoracic splanchnic nerves for the management of abdominal cancer pain, randomized trial","volume":"22","author":"Amr","year":"2018","journal-title":"Eur. J. Pain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archsurg.135.3.332","article-title":"Thoracoscopic Splanchnicectomy for Pain Relief in Unresectable Pancreatic Cancer","volume":"135","author":"Pietrabissa","year":"2000","journal-title":"Arch. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36076\/ppj.2024.27.1","article-title":"Efficacy and Safety of Celiac Plexus Neurolysis Versus Splanchnic Nerve Neurolysis in the Management of Abdominal Cancer Pain: A Meta-analysis of 359 Patients","volume":"27","author":"Lu","year":"2024","journal-title":"Pain Physician"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2147\/JPR.S266689","article-title":"Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac Plexus Neurolysis","volume":"13","author":"Comlek","year":"2020","journal-title":"J. Pain Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1213\/ANE.0000000000002903","article-title":"Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center","volume":"126","author":"Carvajal","year":"2018","journal-title":"Anesth. Analg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3349\/ymj.2012.53.3.649","article-title":"Efficacy of Epidural Analgesia in Patients with Cancer Pain: A Retrospective Observational Study","volume":"53","author":"Jeon","year":"2012","journal-title":"Yonsei Med. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"455","DOI":"10.21037\/jgo-20-361","article-title":"Skeletal metastases in advanced pancreatic ductal adenocarcinoma: A retrospective analysis","volume":"12","author":"Puri","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_70","unstructured":"Health Quality Ontario (2016). Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review. Ont. Health Technol. Assess. Ser., 16, 1\u2013202."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"ons187","DOI":"10.1227\/01.NEU.0000335645.67282.03","article-title":"Computed tomography-guided percutaneous cordotomy for intractable pain in malignancy","volume":"64","author":"Kanpolat","year":"2009","journal-title":"Oper. Neurosurg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/pme.12629","article-title":"Dorsal Root Ganglion Pulsed Radiofrequency for the Management of Intractable Vertebral Metastatic Pain: A Case Series","volume":"16","author":"Arai","year":"2015","journal-title":"Pain Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:03:00Z","timestamp":1790589780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":72,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193127"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193127","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]}}}